Education Tenders

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion Within the Framework of the So-Called Open House Procedure.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion as Part of the So-Called Open House Procedure.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion as Part of the So-Called Open House Procedure.

Open House Drug Discount Contracts in Accordance with Section 130A Paragraph 8C Sgb V Paclitaxel, Atc L01cd01

Open House Drug Discount Agreements Formoterol and Beclometasone, Atc R03ak08

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Paliperidone (Exclusively 1-Month Depot), Atc N05ax13 for the Period January 1St, 2024 - December 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V I. V. M. Paragraph 31 Paragraph 1 Sgb V on Blood Sugar Test Strips, for the Period January 1St, 2024 - December 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Tildrakizumab, Atc L04ac17 for the Period January 1St, 2024 - December 31St, 2025

Medicines with the Active Ingredient Combination Timolol and Tafluprost (Atc: S01ed70)

Medicines with the Active Ingredient Distigmine (Atc: N07aa03)